These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4982322)

  • 1. Chromosomal changes in 20-methylcholanthrene induced sarcomas in mice in relation to time of appearance of the tumours.
    Hansteen IL; Refsum SB
    Virchows Arch B Cell Pathol; 1969; 4(1):1-7. PubMed ID: 4982322
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell proliferation and time of appearance of sarcomas induced with 20-methylcholanthrene in mice.
    Hansteen IL; Refsum SB
    Virchows Arch B Cell Pathol; 1969; 4(1):8-15. PubMed ID: 4982328
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous sarcomas induced by mitomycin C in mice: comparisons of occurrence, transplantability and histology between sarcomas induced by actinomycin S and 3-methylcholanthrene.
    Ikegami R; Akamatsu Y; Haruta M
    Acta Pathol Jpn; 1967 Nov; 17(4):495-501. PubMed ID: 4173029
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific chromosome changes in malignancy: studies in rat sarcomas induced by two polycyclic hydrocarbons.
    Levan O; Levan A
    Hereditas; 1975; 79(2):161-98. PubMed ID: 806563
    [No Abstract]   [Full Text] [Related]  

  • 5. [Caryology of rhabdomyosarcomas induced with 3-methylcholanthrene].
    Basso M
    Tumori; 1972; 58(2):107-19. PubMed ID: 4116018
    [No Abstract]   [Full Text] [Related]  

  • 6. A spontaneously metastasizing 20-methylcholanthrene-induced rhabdomyosarcoma and its transformation to ascites form in the CBA mouse.
    Mellgren J; Bartholdsson E; Boeryd B; Norrby K
    Acta Pathol Microbiol Scand; 1966; 68(4):535-46. PubMed ID: 5958849
    [No Abstract]   [Full Text] [Related]  

  • 7. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity.
    Kearney R; Nelson DS
    Aust J Exp Biol Med Sci; 1973 Dec; 51(6):723-35. PubMed ID: 4788454
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of Candida albicans glycoprotein on 3-methylcholanthrene induced malignancy in newborn rodents.
    Mankowski ZT
    Mycopathol Mycol Appl; 1971 May; 44(2):95-100. PubMed ID: 4930335
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumour cell volume changes in vivo induced by heparin.
    Norman M; Norrby K
    Pathol Eur; 1971; 6(3):268-77. PubMed ID: 5114236
    [No Abstract]   [Full Text] [Related]  

  • 10. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y; Fukushima M; Sato T; Komaba M; Yagihashi H
    Tohoku J Exp Med; 1971 Feb; 103(2):195-201. PubMed ID: 5580594
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence of a G1 regulation of circadian proliferation in mouse methylcholanthrene-induced sarcomas.
    Focan C; Barbason H; Betz EH
    Eur J Cancer (1965); 1979 Nov; 15(11):1371-6. PubMed ID: 527628
    [No Abstract]   [Full Text] [Related]  

  • 12. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ; Focan C; Boniver J; Betz EH
    Pathol Eur; 1975; 10(4):317-25. PubMed ID: 1208123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age at treatment and dose of 3-methylcholanthrene on development of leukemia and sarcoma in AKR mice.
    Whitmire CE; Salerno RA; Merold VA; Rabstein LS
    J Natl Cancer Inst; 1972 Nov; 49(5):1411-5. PubMed ID: 4650202
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific immunoprotection with 3 M KCl solubilized tumor antigen.
    Kahan BD; Pellis NR
    J Surg Res; 1975 Mar; 18(3):263-9. PubMed ID: 1134089
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection of tumor-host cell hybrids from polyoma virus- and methylcholanthrene-induced sarcomas.
    Fenyö EM; Wiener F; Klein G; Harris H
    J Natl Cancer Inst; 1973 Dec; 51(6):1865-75. PubMed ID: 4358146
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the oncogenic response of newborn mice to various chemical carcinogens. II. Induction of subcutaneous sarcoma with 9,10-dimethyl-1,2-benzanthracene and with 20-methylcholanthrene in Swiss mice C57BL and C3Hf/Gs].
    Tridente G; Mazzarella L; Pennelli N; Fiore-Donati L
    Boll Soc Ital Biol Sper; 1964 Jun; 40(11):607-10. PubMed ID: 5876350
    [No Abstract]   [Full Text] [Related]  

  • 17. Sarcoma induction in mice by methylcholanthrene. The influence of thymus grafting and of castration.
    Marchant J
    Br J Cancer; 1969 Jun; 23(2):377-82. PubMed ID: 5788046
    [No Abstract]   [Full Text] [Related]  

  • 18. [Demonstration of a nycthemeral rhythm of cell division in sarcomas induced by methylcholanthrene].
    Focan C; Barbason H; Betz EH
    C R Acad Hebd Seances Acad Sci D; 1973 Apr; 276(14):2229-32. PubMed ID: 4201167
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas.
    Evans R; Lawler EM
    Int J Cancer; 1980 Dec; 26(6):831-5. PubMed ID: 7216549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell clones with different sensitivity to cytostatic drugs in methylcholanthrene-induced mouse sarcomas.
    Håkansson L; Tropé C
    Acta Pathol Microbiol Scand A; 1974 Jan; 82(1):41-7. PubMed ID: 4827350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.